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Zika virus infection reprograms global transcription of
host cells to allow sustained infection
Shashi Kant Tiwari1,*, Jason Dang1,2,*, Yue Qin1, Gianluigi Lichinchi1,3, Vikas Bansal1 and Tariq M Rana1,4
Zika virus (ZIKV) is an emerging virus causally linked to neurological disorders, including congenital microcephaly and Guillain–
Barré syndrome. There are currently no targeted therapies for ZIKV infection. To identify novel antiviral targets and to elucidate
the mechanisms by which ZIKV exploits the host cell machinery to support sustained replication, we analyzed the transcriptomic
landscape of human microglia, fibroblast, embryonic kidney and monocyte-derived macrophage cell lines before and after ZIKV
infection. The four cell types differed in their susceptibility to ZIKV infection, consistent with differences in their expression of
viral response genes before infection. Clustering and network analyses of genes differentially expressed after ZIKV infection
revealed changes related to the adaptive immune system, angiogenesis and host metabolic processes that are conducive to
sustained viral production. Genes related to the adaptive immune response were downregulated in microglia cells, suggesting
that ZIKV effectively evades the immune response after reaching the central nervous system. Like other viruses, ZIKV diverts
host cell resources and reprograms the metabolic machinery to support RNA metabolism, ATP production and glycolysis.
Consistent with these transcriptomic analyses, nucleoside metabolic inhibitors abrogated ZIKV replication in microglia cells.
Emerging Microbes & Infections (2017) 6, e24; doi:10.1038/emi.2017.9; published online 26 April 2017
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INTRODUCTION
Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae
family,1,2 which includes West Nile (WNV), yellow fever, chikungu-
nya, dengue and Japanese encephalitis viruses.2 These viruses cause
mosquito-borne diseases transmitted by the Aedes genus.2 ZIKV may
also be transmitted sexually and vertically.3,4 ZIKV was first discovered
460 years ago in samples taken from a sentinel rhesus monkey in the
Zika forest of Uganda, and has since been isolated from mosquitoes
and humans.5,6 Various epidemiological studies have revealed a
worldwide spread of ZIKV to geographic areas ranging from Asia
and the Pacific to, most recently, the Americas.1 The rapid spread of
ZIKV from Asia to the Americas has affected 430 countries. Due to
its sporadic nature and mild symptoms, ZIKV infection was initially
ignored. Approximately 80% of ZIKV infections are asymptomatic,
and the most common symptoms include fever, arthralgia, rash,
myalgia, edema, vomiting and non-purulent conjunctivitis.7 However,
ZIKV infection in pregnant women has been linked to the increasing
incidence of congenital microcephaly and other disorders such as
placental insufficiency, fetal growth retardation and fetal death.
Emerging evidence suggests that ZIKV causes mild symptoms in
non-pregnant individuals, but it has also been associated with
neurological abnormalities and Guillain–Barré syndrome.8–11
Female Aedes mosquitoes act as vectors to transmit ZIKV through
the skin of the mammalian host, which is followed by infection of
permissive cells through specific receptors. Current reports indicate
that dermal fibroblasts, dendritic cells, neural progenitor cells and
epidermal keratinocytes are permissive to ZIKV infection, whereas
placental trophoblasts are resistant due to constitutive release of type
III interferon.12–16 Interferon knockout mouse models have also
shown susceptibility to ZIKV infection.17–19 However, the pathogen-
esis of ZIKV infection remains poorly understood. In this study, we
analyzed transcriptomic changes induced by ZIKV infection in four
human cell lines (microglia, fibroblast, macrophage and human
embryonic kidney cells) to identify genes that could be developed as
potential therapeutic targets and to provide insight into the interaction
between ZIKV and the host cell.
MATERIALS AND METHODS
Cell lines and culture conditions
Vero, microglia, THP-1, BJ and 293FT cells were maintained under
standard culture conditions at 37 °C in a 5% CO2 atmosphere. In
brief, Vero cells, derived from African green monkey kidney cells, were
maintained in Eagle's minimum essential medium supplemented with
10% (vol/vol) fetal bovine serum (FBS) and antibiotics. THP-1 cells, a
human leukemia monocytic cell line, were cultured in RPMI 1640
medium supplemented with 10% FBS and 50 μM β-mercaptoethanol
(Sigma, St Louis, MO, USA). THP-1 cells were differentiated into
macrophages by treatment with 5 ng/mL phorbol-12-myristate-13-
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acetate (PMA) overnight. The following day, the medium was replaced
with fresh medium without PMA. 293FT human embryonic kidney
cells and the human fibroblast cell line BJ were cultured in Dulbecco’s
modified Eagle’s medium (Invitrogen, Carlsbad, CA, USA) supple-
mented with 10% FBS. The human microglial cell line (kindly
provided by Dr Jon Karn lab at the Case Western Reserve University,
Cleveland, OH, USA) was cultured in Dulbecco’s modified Eagle’s
medium with high-glucose supplemented with 10% FBS and 1%
penicillin/streptomycin.
ZIKV propagation and infection of cell lines
ZIKV prototype MR766 was propagated in the low-passage Vero cell
line. Vero cells were infected with virus at a multiplicity of infection
(MOI) of 1 in Eagle’s minimum essential medium supplemented with
10% FBS. The medium was replaced with fresh medium 24 h after
infection, and the viral supernatant was collected at 48 h post
infection. Viral titers were assessed using iScript One-Step RT-PCR
kit (Bio-Rad, Hercules, CA, USA), and the viral copy number was
calculated from a standard curve of in vitro transcribed viral RNA
transcripts. For infection, cell lines were seeded in six-well culture
plates at a density of 1× 106 cells per well. ZIKV, diluted to the desired
MOI (1), was added to the cells and the plates were incubated at 37 °C
in a 5% CO2 atmosphere for 6, 12, 24 or 48 h. As controls, cells were
incubated with culture supernatants from uninfected Vero cells
(mock-infected controls). At the indicated times post infection, cell
supernatants were collected for determination of viral copy number.
Immunofluorescence microscopy
To assess ZIKV infection, cells were collected at 24 h following
infection and immunostained as described previously.16 In brief,
ZIKV- and mock-infected cells were fixed with 4% paraformaldehyde
in phosphate-buffered saline (PBS) for 20 min at room temperature.
Cells were blocked by incubation in 3% BSA and 0.1% Triton X-100
for 2 h at room temperature and then incubated overnight at 4 °C with
ZIKVE/anti-flavivirus group antigen antibody (1:500, mouse, Milli-
pore, Temecula, CA, USA; MAB10216), which is directed against the
flavivirus envelope protein. Cells were washed with PBS and incubated
for 2 h at room temperature with fluorescein isothiocyanate-
conjugated anti-mouse IgG. The nuclei were stained using Hoechst
33258 (Invitrogen). Immunostained cells were imaged using a Leica
fluorescence microscope (DMI 3000B) (Leica Microsystem, Wetzlar,
Germany).
RNA extraction, cDNA synthesis and qRT-PCR
For cellular messenger RNA (mRNA) analysis, RNA was extracted
from the cell lines using an RNeasy Mini kit (Qiagen, Hilden,
Germany), following the manufacturer’s instructions. RNA samples
were treated with RNase-free DNase (Qiagen) and complementary
DNA (cDNA) was generated from total RNA (500 ng per sample)
using iScript Mastermix (Bio-Rad), according to the manufacturer’s
instructions. Quantitative PCR (qPCR) was performed with SYBR
Green PCR MasterMix (Bio-Rad) using a Roche LightCycler 480
(Roche Diagnostics, Basel, Switzerland).
RNA-Seq and data analysis
For RNA-seq analysis, RNA was extracted from the cell lines using an
RNeasy Mini kit (Qiagen), following the manufacturer’s instructions.
RNA was ribo-depleted, and RNA sequencing was performed using an
Illumina NextSeq 500 (Illumina, San Diego, CA, USA) with an average
of 20 million reads per sample at The Scripps Research Institute NGS
Core facility. The single-end reads that passed Illumina filters were
filtered for reads aligning to transfer RNA, ribosomal RNA, adapter
sequences and spike-in controls. The reads were then aligned to UCSC
hg19 reference genome using TopHat (v 1.4.1, Baltimore, MD, USA).
DUST scores were calculated with PRINSEQ Lite (v 0.20.3, open
source software), and low-complexity reads (DUST44) were removed
from the BAM files. The alignment results were parsed via the
SAMtools to generate SAM files. Read counts to each genomic feature
were obtained with the htseq-count program (v 0.6.0) using the
‘union’ option. After removing absent features (zero counts in all
samples), the raw counts were imported into R/Bioconductor package
DESeq2 to identify differentially expressed genes among the samples.
DESeq2 normalizes counts by dividing each column of the count table
(samples) by the size factor of this column. The size factor is calculated
by dividing the samples by the geometric means of the genes. This
brings the count values to a common scale suitable for comparison.
P-values for differential expression were calculated using binomial
test for differences between the base means of two conditions. The
P-values were adjusted for multiple test correction using the Benja-
mini–Hochberg algorithm to control the false discovery rate. Cluster
analyses, including principal component analysis and hierarchical
clustering, were performed using standard algorithms and metrics.
Gene ontology analyses on biological processes were performed using
The Database for Annotation, Visualization and Integrated
Discovery.20 Grouped functional pathway/gene ontology network
analyses were performed using Cytoscape with the ClueGo add-
on.21,22
Drug treatment
Human microglial cell line was infected with ZIKV at MOI of 1 in cell
medium containing metabolic inhibitors such as 5-fluorouracil
(ab142387; Abcam, Cambridge, UK) and floxuridine (4659; Tocris,
Bristol, UK) in cell medium containing 1 and 10 μM of each drug or
1% (vol/vol) dimethylsulfoxide (DMSO) as a control. After 48 h post
infection, cellular RNA was extracted using Trizol and cDNA was
synthesized by iScript Mastermix (Bio-Rad), as per the manufacturer’s
instructions. ZIKV RNA was quantified by using specific primers by
SYBR Green PCR Master Mix (Bio-Rad), using a Roche LightCycler
480. Further, immunocytochemistry was also performed in microglial
cells for the detection of ZIKV infection using flavivirus group
antigen-specific antibody (Millipore).
RESULTS
Cell-type-specific ZIKV replication and infection
To analyze factors contributing to ZIKV pathogenesis, we selected four
human cell lines, microglia, BJ (foreskin fibroblast), 293FT (embryo-
nic kidney) and THP-1-derived macrophages (monocyte-derived
macrophage), and inoculated them with ZIKV produced in Vero
and BHK cells at a MOI of 1 (Supplementary Figure S1). The choice of
cell lines was driven by a desire to understand different aspects of
ZIKV pathogenesis. Microglia cells model the resident macrophages in
the brain and provide information on how they may contribute to
neuroinflammation and other ZIKV-associated neurodegenerative
disorders, such as Guillain–Barré syndrome. BJ cells were selected to
model dermal infection, the primary route of mosquito-driven ZIKV
infection. The 293FT human embryonic kidney cell line is well known
for robust lentivirus production and may provide an ideal host for
ZIKV replication as well. Last, THP-1 macrophages provide a model
of the effect of ZIKV infection on a host cell critical for the immune
response. ZIKV expression was assessed by immunofluorescent
staining of cells with an antibody against the ZIKVE flavivirus
envelope protein at 24 h post infection (hpi). ZIKV infection was
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most marked in microglia cells, followed by BJ, 293FT and THP-1-
derived macrophages (Figures 1A–1D). These findings were confirmed
by one-step qPCR with reverse transcription (RT-qPCR) of viral RNA
in the cell supernatants, which showed statistically significant differ-
ences in the levels of viral transcripts between microglia and THP-1-
derived macrophages at 24 and 48 hpi (Figure 1E). This marked
difference in ZIKV susceptibility is notable because both cell types are
macrophages; microglia cells are microglial and THP-1-derived
macrophages are monocyte-derived.
We next analyzed changes in the transcriptomic landscapes of the
four cell types after ZIKV infection to identify potential key regulators
responsible for the cell-type-specific differences in ZIKV replication.
For this, total RNA was extracted from mock- and ZIKV-infected cell
lines at 24 hpi and analyzed by Illumina NextSeq 500. We elected to
Figure 1 Variable ZIKV infection and replication levels in different cell types. (A–D) Immunohistochemistry of ZIKV gene expression in microglial, fibroblast
(BJ), kidney (293FT) and macrophage (THP-1) cell lines at 24 hpi. Cells were stained with anti-flavivirus envelope protein (ZIKVE), and nuclei were
visualized with Hoechst 33258 (Invitrogen). (E) ZIKV replication assessed by one-step quantitative PCR with reverse transcription analysis of viral
supernatants at the indicated times post infection. Data are presented as the mean±SEM of n=3. *Po0.05, **Po0.01, ***Po0.001; ns, not significant
by two-way analysis of variance. See also Supplementary Figure S1. Zika virus, ZIKV.
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examine gene expression at 24 hpi to assess the effects of ZIKV
infection immediately following the early innate immune response
(Supplementary Figures S1C–S1E). Figure 2 shows the data presented
in Circos plots, in which the fold change for differentially expressed
genes (shown in inner circles) are plotted in contrast with the overall
gene expression level (in outer circles) for microglia, BJ, 293FT and
THP-1-derived macrophages (Figures 2A–2D, respectively). Interest-
ingly, the level of ZIKV expression and the impact of ZIKV infection
on the transcriptome were inversely correlated. Thus, microglia cells
showed the fewest changes in gene expression following infection
(Figure 2A), followed by BJ (Figure 2B), 293FT (Figure 2C) and
THP-1-derived macrophages (Figure 2D). Furthermore, the magni-
tude of the gene expression changes also differed between the cell
types, with the differentially expressed genes in THP-1-derived
macrophages displaying the biggest differences between mock- and
ZIKV-infected cells (Figure 2E).
Analysis of viral response genes identifies potential cell-type-specific
regulators
To identify genes that may account for the different levels of ZIKV
expression in the four cell lines, we analyzed the expression of
endogenous viral response genes before infection. We hypothesized
Figure 2 Changes in the transcriptional landscape following ZIKV infection. (A–D) Circos plots of transcriptional changes in microglia (A), BJ (B), 293FT (C)
and THP-1-derived macrophages (D) at 24 hpi. The outer circles (blue, brown, green and magenta) represent the expression levels of the transcripts before
infection. The inner circles represent the differentially expressed genes, with the size of the lines indicating the fold change in expression. Genes upregulated
and downregulated by ZIKV infection are shown in red and blue, respectively. (E) Circos plot showing differentially expressed genes in all four cell types. The
number of differentially expressed genes and the magnitude of the expression change are inversely correlated with ZIKV expression. Upregulated genes are in
red and downregulated genes are in blue. Outer to inner circles: THP-1, 293FT, BJ and microglia. Zika virus, ZIKV.
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that the initial ZIKV viral entry and replication mechanisms might be
dependent on the expression levels of specific host genes. Thus, genes
from the human GRCh38.p5 database in Ensembl associated with the
following gene ontology terms were analyzed in the mock-infected
cells: ‘response to virus,’ ‘modulation of virus host gene expression,’
‘viral transcription’ and ‘viral release from host cell’ (Figures 3A and 3B;
Supplementary Figures S2A–S2D; Supplementary Table S1).
Consistent with our hypothesis, THP-1-derived macrophages,
which were the most resistant to ZIKV infection, expressed the
greatest number of viral response genes and immune-related genes,
whereas microglia cells express the fewest (Supplementary Figures S2E
and S2F; Supplementary Table S2). Genes that were uniquely or highly
expressed in THP-1-derived macrophages but showed low expression
in microglia were analyzed as potential antiviral ZIKV factors.
Interestingly, expression of immune regulatory molecules, including
CCL3, CCL4, CCL5, TNF, IRF5, CXCL10, OAS1, TLR7, TLR8, and
IL27, was highest in THP-1-derived macrophages, indicating that they
are primed to mount a vigorous defense as part of the initial innate
immune response to ZIKV and to elicit greater transcriptional changes
in response to ZIKV infection (Figures 2E and 3B). Comparison of
genes differentially expressed in the four cell types before infection
revealed high expression of CD4 in THP-1-derived macrophages and
low expression of CHMP4C (charged multivesicular body protein 4C).
CHMP4C is a component of the ESCRT-III family responsible for
surface receptor degradation and viral budding.23 Further mechanistic
studies will be necessary to determine which of these viral response
and immune-related genes might be vital for regulating ZIKV
expression.
We also examined the differential expression of cell surface receptor
genes in the four cell types prior to ZIKV infection to identify
potential antiviral receptors that may confer greater ZIKV resistance
on THP-1-derived macrophages. Heat map clustering of cell surface
receptor genes identified several genes that were expressed highly in
THP-1 compared with the other cell types, including CD86, LY6D,
CXCL10, CD48 and IL12RB1 (Figures 3C and 3D; Supplementary
Table S3). Gene ontology analysis of these and other genes showing
selectively high expression in THP-1-derived macrophages revealed an
enrichment of genes involved in cell activation, immune response and
cell receptor signaling (Figure 3E). These analyses of the steady-state
expression of endogenous genes in the four cell lines before ZIKV
infection have identified a number of antiviral genes highly expressed
in THP-1-derived macrophages, suggesting that they could be
exploited to therapeutic effect. As each cell line expresses specific sets
of genes that are unique to that cell type, a correlation between steady-
state expression of viral response genes and viral susceptibility may not
imply a causal relationship and further functional validation is
necessary to confirm a role in ZIKV infection.
ZIKV infection modulates the metabolic and transcriptional
landscape
To determine the effects of ZIKV infection on the host transcriptome,
we analyzed differentially expressed genes between mock- and ZIKV-
infected cell lines at 24 hpi. As mentioned above, the total number of
differentially expressed genes in ZIKV-infected cells was inversely
correlated with the level of ZIKV infection, with the least- and most-
marked changes occurring in microglia and THP-1-derived macro-
phages, respectively (Figures 1 and 2E). In-depth analysis of the
differentially expressed genes revealed that ZIKV infection elicited a
similar pattern of gene expression changes between BJ and 293FT cells,
and between microglia and THP-1-derived macrophages, both macro-
phage cell types; however, the fold change in expression is much
greater in THP-1-derived macrophages (Figure 4A; Supplementary
Table S4). Predictive network analyses suggested that a significant
portion of the differentially expressed genes following ZIKV infection
interact to regulate common pathways such as including mRNA
processing, metabolic processes, RNA processing and cellular compo-
nent disassembly (Figure 4B; Supplementary Figures S3A–S3D).
Further, clustering analysis highlighted the distinct patterns of gene
expression changes in the ZIKV-infected cells (right vertical bar in
Figure 4A). Analysis of genes that were predominantly upregulated in
microglia and THP-1 macrophages, and downregulated in BJ and
293FT cells (red on the vertical bar in Figure 4A) indicated that they
are associated with transcriptional regulators, RNA metabolic pro-
cesses and macromolecule biosynthesis (Figure 4C). Genes upregu-
lated in THP-1 macrophages and downregulated in all other cell lines
(green bar) included IL1B, CD4, IL27RA and FCER1G which act as
positive regulators of the adaptive immune response, Fc epsilon RI
signaling pathway, and complement and coagulation cascades
(Figures 4A and 4E). Interestingly, these genes are downregulated in
microglia, BJ and 293FT. These findings help to explain why THP-1-
derived macrophages, which have the highest expression of innate
immune genes in the uninfected state and the greatest upregulation of
adaptive immune response genes post infection, have the lowest level
of ZIKV expression.
The cluster of genes downregulated by ZIKV infection in microglia
and BJ but upregulated in 293FT and THP-1-derived macrophages
(magenta bar, Figure 4A) included several key genes that regulate virus
receptor activity, protein kinase B activity and angiogenesis
(Figure 4F). A notable gene in this cluster is the viral entry receptor
AXL, which has previously been associated with ZIKV
pathogenesis.12,24 In contrast, the gene clusters downregulated in the
macrophage lines (yellow bar in Figure 4A), and particularly in
THP-1-derived macrophages, are strongly associated with translational
elongation and various cellular metabolic processes (Figure 4D).
Finally, genes differentially expressed in ZIKV-infected microglia and
THP-1-derived macrophages (blue bar in Figure 4A) were related to
metabolic processes (Figure 4G). Viruses are obligate parasites that
exploit the host’s metabolic processes to reproduce.25–27 Understand-
ing the mechanisms by which ZIKV alters the host cell metabolism
may thus provide additional novel therapeutic targets. Further
examination of the roles of metabolic control genes such as TERT,
ALDH7A1, CREB5, EAPP, and NDUFA11 as they relate to ZIKV
infection may provide further insights into ZIKV pathogenesis.
As metabolic processes are the most dysregulated pathways during
ZIKV infection at the transcriptome level, we hypothesized that
inhibition of these pathways could be exploited for therapeutic effects.
To determine the role of host cell metabolism in ZIKV replication, we
utilized nucleoside metabolic inhibitors because nucleoside analogs
have been reported to inhibit flaviviruses by interfering with RNA
synthesis, methyl transferases and thymidine synthesis pathway.28–30
We utilized nucleoside metabolic inhibitors flurouracil and floxuridine
in our experiments. Microglia cells were treated with flurouracil or
floxuridine and inoculated with ZIKV. The effect of the antimetabolites
floxuridine (Figures 5A and 5B) and flurouracil (Figures 5C and 5D)
on ZIKV replication was assessed 48 hpi at the RNA and protein level
by RT-qPCR and immunohistochemistry, respectively. Although both
nucleoside analogs affected ZIKV, but the treatment of floxuridine
inhibited ZIKV more efficiently in a dose-dependent manner than
flurouracil. These findings show that ZIKV replication is sensitive to
nucleoside metabolic pathways revealed by transcriptomic analyses.
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Figure 3 Cell-type-specific differences in steady-state expression of viral response genes reveal potential antiviral targets. (A) Hierarchical clustering of genes
associated with ‘response to virus’ (top) and the fold change in expression of the same genes at 24 hpi (bottom). Left scale bar: 0:10 represents gene
expression log2 (RPKM+1) for all cell lines. Right scale bar: −2:2 represents fold change in gene expressed between mock-treated and ZIKV-infected cells.
Also see Supplementary Table S1. (B) Pre-infection expression levels of genes associated with ‘response to virus.’ (C) Hierarchical clustering of
genes associated with ‘cell surface’ (top) and their associated fold change in expression following infection (bottom). Also see Supplementary Table S3.
(D) Differential gene expression of cell surface proteins and receptors involved in cell activation, immune response and cell surface signaling in THP-1-
derived macrophages. See also Supplementary Figure S2. (E) Gene ontology analysis of cell surface genes highly expressed specifically in THP-1. Zika
virus, ZIKV.
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Figure 4 Analysis of differentially expressed genes post ZIKV infection identifies key pathways exploited by ZIKV. (A) Hierarchical clustering of differentially
expressed genes following ZIKV infection, showing cell-type-specific transcriptional changes. Genes displayed have fold changes of 41.4 and Po0.05 in at
least one cell type. The vertical bar to the right indicates the differentially expressed gene clusters described by color in the text. Also see Supplementary
Table S4. (B) Interactome of differentially expressed genes across all cell types. (C) Gene ontology analysis of ‘red cluster’ genes, which are upregulated in
microglia and THP-1-derived macrophages. (D) Gene ontology analysis of ‘yellow cluster’ genes, which are mostly downregulated in microglia and THP-1-
derived macrophages. (E) Analysis of ‘green cluster’ genes, which are upregulated only in THP-1. (F) Analysis of ‘magenta cluster’ genes, which are
upregulated in 293FT and THP-1-derived macrophages. (G) Analysis of ‘blue cluster’ genes, which are only upregulated in microglia cells. See also
Supplementary Figure S3. Zika virus, ZIKV.
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DISCUSSION
In this study, we analyzed the transcriptional profiles of human
microglia, fibroblast, kidney and macrophage cell lines to explore the
host factors that contribute to susceptibility to ZIKV infection, viral
replication and host symptomology. ZIKV expression was significantly
different among the cell lines, with a notably large difference between
microglial cells and THP-1 monocyte-derived cells, despite both being
macrophage cell lines. A recent study analyzing the cell line suscept-
ibility in across cell types—including placental, genitourinary, neuro-
muscular, retinal, respiratory and liver—and species further validate
our findings. Similar to our results, the study showed that THP-1-
derived macrophages are relatively resistant to viral infection when
compared to HEK, HeLa and SF268 neurons.31
By analyzing steady-state gene expression levels in cells before ZIKV
infection, we identified several antiviral response genes that may
contribute to the significant difference in ZIKV expression between
cell types. For example, the Toll-like receptors TLR7 and TLR8 are
functionally related genes and are highly expressed in THP-1-derived
macrophages compared with microglia, 293FT and BJ cells. As TLR7
and TLR8 are activated by single-stranded RNAs, they likely allow
THP-1 macrophages to recognize flaviviruses and produce a more
robust innate immune response.32,33 Moreover, THP-1-derived
macrophages express tumor necrosis factor α (TNF-α) as well as
CD86, a co-stimulatory molecule that has been implicated in the early
and late acute phases of dengue infection. However, it is important to
note that differences in basal level gene expression between cell types
does not necessarily equate to functional significance because each cell
type expresses unique sets of genes. Further experiments will be
required to determine which of these antiviral response genes regulate
ZIKV expression.
Other flaviviruses, such as WNV, dengue, yellow fever and Japanese
encephalitis viruses, have shown a remarkable ability to evade the
innate and adaptive immune systems.34 Complement proteins recog-
nize target pathogens and act as opsonins to promote recruitment of
phagocytes and lysis of infected cells. Previous studies have shown that
the complement system can be compromised by the flavivirus
nonstructural protein NS1, which interacts with the complement
regulatory glycoprotein factor H.35 In addition, flaviviruses are able to
evade the antibody and cellular immune response by affecting antigen
presentation. The error-prone nature of flavivirus RNA polymerases
leads to the accumulation of mutations and subsequent alterations in
viral proteins that may help them to escape recognition by neutralizing
or inhibitory antibodies.35
We showed that ZIKV affects the adaptive immune response and
complement cascade by modulating genes such as IL1B, CD4, IL27RA
and A2M. Flaviviruses downregulate CD4 mRNA through an ns5-
dependent mechanism, thereby dysregulating both the innate and
adaptive immune systems.36 Moreover, these findings are corrobo-
rated by a recent study analyzing transcriptional changes in ZIKV-
infected human neural stem cells in which leukocyte activation,
cytokine production and defense response pathways were significantly
dysregulated.37 In addition, IL1B has previously been linked to WNV.
IL-1β is present at increased levels in the plasma and cortical neurons
of WNV patients, and it plays a key role in restricting virus
Figure 5 Nucleoside metabolic inhibitors attenuate ZIKV replication. (A) ZIKV replication assessed by RT-qPCR 48 hpi in mock, ZIKV only, ZIKV plus 1 μM
floxuridine (FUDX1) or ZIKV plus 10 μM floxuridine (FUDX10)-treated microglia. Data are presented as the mean± sem of n=3. *Po0.05, **Po0.01 by
t-test. (B) Immunohistochemistry of anti-flavivirus envelope protein (ZIKVE) expression in mock, ZIKV only, ZIKV plus FUDX1 or ZIKV plus FUDX10-treated
microglia. (C) ZIKV replication assessed by RT-qPCR analysis 48 hpi in mock, ZIKV only, ZIKV plus 1 μM flurouracil (FU1) or ZIKV plus 10 μM flurouracil
(FU10)-treated microglia. Data are presented as the mean±SEM of n=3. *Po0.05, **Po0.01 by t-test. (D) Immunohistochemistry of ZIKVE expression in
mock, ZIKV only, ZIKV plus 1 μM FU1 or ZIKV plus FU10-treated microglia. Quantitative PCR with reverse transcription, RT-qPCR; Zika virus, ZIKV.
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replication.38 IL-1β acts in concert with type I interferon (IFN) and
the NLRP3 inflammasome to restrict WNV replication. Interestingly,
IL1B expression was upregulated by ZIKV in THP-1-derived macro-
phages. But downregulated in microglia cells, which is consistent with
our finding that viral replication is higher in the microglial-derived
than in the monocyte-derived macrophage. These data imply that,
although ZIKV is actively targeted by the innate and adaptive immune
responses via monocyte-derived macrophages, it is able to effectively
evade the microglial immune response once it passes through the
blood–brain barrier and reaches the central nervous system.
Endothelial cells are one of the cell types infected by dengue virus,
also a flavivirus, and the breakdown in endothelial barrier function
causes the vascular leakage associated with hemorrhagic fever. Dengue
virus type 2 suppresses TNF-α-mediated hyperpermeability and
angiogenesis by modulating type I IFN.39 Cases of thrombocytopenia
and subcutaneous bleeding have been observed in Zika patients.40 Our
data suggest that ZIKV may affect angiogenesis and endothelial cell
integrity. These findings may provide insights into the molecular
mechanisms by which ZIKV passes through the blood–brain barrier.
Last, we identified a large number of differentially expressed genes
associated with cellular metabolic processes following ZIKV infection.
Previous studies have drawn attention to the role of virus-mediated
reprogramming of host metabolic processes in pathogenesis. In
accordance with our findings, transcriptional alterations in human
neural stem cells inoculated with MR766 strain ZIKV revealed
significant remodeling of nucleic acid metabolic processes and
macromolecule biosynthesis.37 RNA viruses such as influenza and
dengue alter fatty acid synthesis and induce glycolysis to promote viral
replication, late gene synthesis and virion assembly.25 The role of
dengue NS3 recruitment of fatty acid synthase to sites of viral
replication has been dissected using RNA interference and small-
molecule inhibitors in an effort to identify potential therapeutic
targets.41 Many other viruses redistribute host cell resources to
promote viral replication by altering the localization of lipids, as seen
with dengue. In addition, viral infection alters the rate of host RNA
metabolism to enhance the availability of nucleotides.27
The molecular mechanisms by which viruses redirect cellular
resources and exploit the host metabolic machinery are largely
unknown. Recent work showed that the adenovirus gene element
E4ORF1 upregulates glucose metabolism by altering the epigenetic
landscape. E4ORF1 interacts with MYC to enhance transcription of
glycolytic enzymes and nucleotide biosynthesis.42 Here we identified
several genes associated with metabolic regulation that are differen-
tially expressed between cell types following ZIKV infection, including
CREB5, TERT, CNIH1, ADAM12 and USE1. One gene that ZIKV may
exploit to regulate the host cell is CREB5. CREB5 (CAMP-responsive
element-binding protein 5) is a transcription factor that regulates
nucleotide and nucleic acid metabolism, transcription, and signal
transduction, and is also highly upregulated in patients with HIV
encephalitis and vaccinia virus infections.43,44 Because cellular meta-
bolism is often a limiting factor in viral replication, nucleoside/
nucleotide-based therapeutics have been developed against a variety of
viruses, including HIV, HBV, HCV, HSV and VZV.26 Indeed,
nucleoside analogs including floxuridine, also known to be effective
against other flaviviruses such as dengue, displayed dose-dependent
inhibition of ZIKV replication.28–30 Further mechanistic studies will be
required to gain a better understanding of how ZIKV hijacks the host
cell metabolic machinery and to aid in the development of ZIKV-
targeted therapeutics.
CONCLUSIONS
ZIKV infection is an emerging disease associated with increased
incidence of neurological disorders including congenital microcephaly
and Guillain–Barré syndrome. Here we analyzed the transcriptomic
changes associated with ZIKV infection across multiple cell types to
identify novel therapeutic targets and understand the host–pathogen
interaction for sustained ZIKV replication. The response to ZIKV is
cell-type specific with the greatest replication found in microglia cells.
ZIKV is highly expressed in microglia and downregulates immune
response genes, whereas high expression of viral response genes in
macrophages confers ZIKV resistance. In addition, ZIKV reprograms
the host metabolic processes to enhance virus replication through the
upregulation of glycolysis and RNA metabolism related genes. Anti-
metabolites floxuridine abrogated ZIKV replication through inhibition
of host nucleoside metabolic pathways. These results reveal that
thymidine synthesis pathway can be exploited to develop novel
therapeutics to treat ZIKV infections.
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